neropals.blogg.se

Net income from continuing operations available to the Company’s common shareholders in the first quarter 2023 was $143 million, or $1.32 per diluted share, versus $139 million, or $1.27 per diluted share, in first quarter 2022.įirst quarter 2023 included COVID-related stimulus grant income of $3 million pre-tax ( $2 million after-tax, or $0.02 per diluted share) versus $6 million pre-tax ( $4 million after-tax, or $0.04 per diluted share) in first quarter 2022. Net income available to Tenet common shareholders from continuing operations per diluted shareĪdjusted diluted earnings per share from continuing operations1 Net income available to Tenet common shareholders from continuing operations

($ in millions, except per share results)

Tenet’s results for first quarter 2023 versus first quarter 2022 are as follows: "Our commitment to expanding access to high-quality, specialty care and maintaining our disciplined approach to managing operations enable us to effectively execute on our growth strategy in each of our businesses." "We delivered a positive start to the year across the organization and in particular, strong growth in revenues, volumes, and Adjusted EBITDA in our ambulatory care segment," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2023. FY 2023 Adjusted EBITDA Outlook increased, now expected to be in the range of $3.210 billion to $3.410 billion.Same-facility system-wide ambulatory surgical cases increased 7.9% versus first quarter 2022 Same-hospital adjusted admissions increased 6.7% versus first quarter 2022.First quarter 2023 Ambulatory Care Adjusted EBITDA of $340 million grew 21.4% over first quarter 2022 excluding grant income.Consolidated Adjusted EBITDA1 in first quarter 2023 of $832 million, including $3 million of grant income.

Adjusted diluted earnings per share from continuing operations1 of $1.42 in first quarter 2023.Net income from continuing operations available to common shareholders in first quarter 2023 was $143 million, or $1.32 per diluted share.